New drug aims to tackle obesity and diabetes together
Disease control
Not yet recruiting
This trial investigates an experimental drug called GUB-UCN2 for people with obesity and type 2 diabetes. The study includes healthy volunteers and those with the conditions, testing the drug alone or alongside standard care. The main goal is to check safety and how the drug beha…
Phase: PHASE1, PHASE2 • Sponsor: Gubra A/S • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC